Nestlé needs to leverage marketing power to beef up Galderma

Nestlé has caught the dermatology fever sweeping through Big Pharma, as companies key in on the specialty sector's growth potential--and Nestlé pushes further into healthcare. But success for Galderma, its recent skincare pickup, depends on the global food giant's good-old-fashioned marketing power. Report

Suggested Articles

China's role as a major producer of global API has come under scrutiny, but so far global tensions haven't affected supply, the FDA said.

Reblozyl, a key drug in Bristol Myers Squibb's Celgene merger, has won a key FDA nod to treat patients with myelodysplastic syndromes.

Wealthy individuals typically don't set out to waste billions of dollars, but amid the COVID-19 pandemic, that’s exactly what Bill Gates plans to do.